Literature DB >> 21694814

Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease.

Marietta Iacucci1, Subrata Ghosh.   

Abstract

The focus of effective management of inflammatory bowel disease, especially Crohn's disease, has shifted from short-term symptom control to long-term modification of disease course and complications. Intestinal healing has achieved prominence as a goal of therapy that influences long-term disease course. We review the natural history of inflammatory bowel disease, the markers of disease control that may reflect outcomes and the specific role of mucosal healing. We may aim at better mucosal healing by appropriate choice of therapy, appropriate combinations of therapy and intervening early in the disease course.

Entities:  

Keywords:  Crohn’s disease; anti-tumour necrosis factor therapy; healing; immunosuppressive drugs; long-term disease course; mucosal ulcers; remission; ulcerative colitis

Year:  2011        PMID: 21694814      PMCID: PMC3105624          DOI: 10.1177/1756283X11398930

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


  57 in total

Review 1.  Review article: the limitations of corticosteroid therapy in Crohn's disease.

Authors:  P J Rutgeerts
Journal:  Aliment Pharmacol Ther       Date:  2001-10       Impact factor: 8.171

2.  Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.

Authors:  Paul Rutgeerts; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; Stefan Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Stephen B Hanauer
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

3.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

Review 4.  Genetics of Crohn disease, an archetypal inflammatory barrier disease.

Authors:  Stefan Schreiber; Philip Rosenstiel; Mario Albrecht; Jochen Hampe; Michael Krawczak
Journal:  Nat Rev Genet       Date:  2005-05       Impact factor: 53.242

5.  Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine.

Authors:  G D'Haens; K Geboes; P Rutgeerts
Journal:  Gastrointest Endosc       Date:  1999-11       Impact factor: 9.427

6.  A reproducible grading scale for histological assessment of inflammation in ulcerative colitis.

Authors:  K Geboes; R Riddell; A Ost; B Jensfelt; T Persson; R Löfberg
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

7.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

8.  Long-term evolution of disease behavior of Crohn's disease.

Authors:  Jacques Cosnes; Stéphane Cattan; Antoine Blain; Laurent Beaugerie; Franck Carbonnel; Rolland Parc; Jean-Pierre Gendre
Journal:  Inflamm Bowel Dis       Date:  2002-07       Impact factor: 5.325

9.  Assessment of small bowel Crohn disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy--feasibility study.

Authors:  Peter B Wold; Joel G Fletcher; C Daniel Johnson; William J Sandborn
Journal:  Radiology       Date:  2003-08-27       Impact factor: 11.105

10.  Prospective comparison of MR enteroclysis with multidetector spiral-CT enteroclysis: interobserver agreement and sensitivity by means of "sign-by-sign" correlation.

Authors:  Sabine Schmidt; Domenico Lepori; Jean-Yves Meuwly; Bertrand Duvoisin; Reto Meuli; Pierre Michetti; Christian Felley; Pierre Schnyder; Guy van Melle; Alban Denys
Journal:  Eur Radiol       Date:  2002-10-24       Impact factor: 5.315

View more
  17 in total

1.  Recognition of microscopic colitis at colonoscopy.

Authors:  Marietta Iacucci; Stefan Urbanski
Journal:  Can J Gastroenterol       Date:  2012-04       Impact factor: 3.522

Review 2.  New endoscopic approach of anti-fibrotic therapy for inflammatory bowel disease.

Authors:  Kenji Suzuki; Hiroyuki Yoneyama
Journal:  Ann Transl Med       Date:  2017-04

Review 3.  Quality of care in Crohn's disease.

Authors:  Govind K Makharia
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 4.  Inflammation and colorectal cancer: colitis-associated neoplasia.

Authors:  Sergei I Grivennikov
Journal:  Semin Immunopathol       Date:  2012-11-16       Impact factor: 9.623

5.  Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.

Authors:  Aditya Garg; Angela Zhao; Sarah L Erickson; Subhajit Mukherjee; Aik Jiang Lau; Laurie Alston; Thomas K H Chang; Sridhar Mani; Simon A Hirota
Journal:  J Pharmacol Exp Ther       Date:  2016-07-20       Impact factor: 4.030

6.  Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis.

Authors:  Kenji Suzuki; Somasundaram Arumugam; Junji Yokoyama; Yusuke Kawauchi; Yutaka Honda; Hiroki Sato; Yutaka Aoyagi; Shuji Terai; Kazuichi Okazaki; Yasuo Suzuki; Shuji Mizumoto; Kazuyuki Sugahara; Raja Atreya; Markus F Neurath; Kenichi Watanabe; Taishi Hashiguchi; Hiroyuki Yoneyama; Hitoshi Asakura
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

Review 7.  Dietary Protein and Amino Acid Supplementation in Inflammatory Bowel Disease Course: What Impact on the Colonic Mucosa?

Authors:  Sandra Vidal-Lletjós; Martin Beaumont; Daniel Tomé; Robert Benamouzig; François Blachier; Annaïg Lan
Journal:  Nutrients       Date:  2017-03-21       Impact factor: 5.717

8.  Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial.

Authors:  Walter Reinisch; Jean-Frédéric Colombel; Geert D'Haens; William J Sandborn; Paul Rutgeerts; Karel Geboes; Joel Petersson; Samantha Eichner; Qian Zhou; Anne M Robinson; Holly A Read; Roopal Thakkar
Journal:  J Crohns Colitis       Date:  2017-04-01       Impact factor: 9.071

9.  Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis.

Authors:  X L Wang; J Zhao; L Qin; M Qiao
Journal:  Braz J Med Biol Res       Date:  2016-04-08       Impact factor: 2.590

10.  Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity.

Authors:  Harmit S Ranhotra; Kyle L Flannigan; Martina Brave; Subhajit Mukherjee; Dana J Lukin; Simon A Hirota; Sridhar Mani
Journal:  Nucl Receptor Res       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.